GB201506806D0 - Rheumatoid arthritis patient stratification - Google Patents

Rheumatoid arthritis patient stratification

Info

Publication number: GB201506806D0
Authority: GB; United Kingdom
Prior art keywords: rheumatoid arthritis; patient stratification; arthritis patient; stratification; rheumatoid
Prior art date: 2015-04-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB1506806.7A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Edinburgh

Original Assignee

University of Edinburgh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-04-22

Filing date

2015-04-22

Publication date

2015-06-03

2015-04-22 Application filed by University of Edinburgh filed Critical University of Edinburgh

2015-04-22 Priority to GBGB1506806.7A priority Critical patent/GB201506806D0/en

2015-06-03 Publication of GB201506806D0 publication Critical patent/GB201506806D0/en

2016-04-21 Priority to PCT/GB2016/051097 priority patent/WO2016170331A1/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Wood Science & Technology (AREA)
Analytical Chemistry (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
Pathology (AREA)
Immunology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

GBGB1506806.7A 2015-04-22 2015-04-22 Rheumatoid arthritis patient stratification Ceased GB201506806D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GBGB1506806.7A GB201506806D0 (en)	2015-04-22	2015-04-22	Rheumatoid arthritis patient stratification
PCT/GB2016/051097 WO2016170331A1 (en)	2015-04-22	2016-04-21	Rheumatoid arthritis patient stratification

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB1506806.7A GB201506806D0 (en)	2015-04-22	2015-04-22	Rheumatoid arthritis patient stratification

Publications (1)

Publication Number	Publication Date
GB201506806D0 true GB201506806D0 (en)	2015-06-03

Family

ID=53298969

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB1506806.7A Ceased GB201506806D0 (en)	2015-04-22	2015-04-22	Rheumatoid arthritis patient stratification

Country Status (2)

Country	Link
GB (1)	GB201506806D0 (en)
WO (1)	WO2016170331A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7582282B2 (en) *	2003-08-29	2009-09-01	Prometheus Laboratories Inc.	Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics
EP2663864B8 (en)	2011-01-14	2019-06-05	iRepertoire, Inc.	Immunodiversity assessment method and its use
WO2013055595A1 (en) *	2011-10-11	2013-04-18	Sequenta, Inc.	Determining responsiveness of autoimmune patients to dmard treatment

2015
- 2015-04-22 GB GBGB1506806.7A patent/GB201506806D0/en not_active Ceased
2016
- 2016-04-21 WO PCT/GB2016/051097 patent/WO2016170331A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2016170331A1 (en)	2016-10-27

Publication	Publication Date	Title
ZA201707334B (en)	2020-02-26	Cell
GB201507368D0 (en)	2015-06-17	Cell
GB201503500D0 (en)	2015-04-15	Cell
GB201518817D0 (en)	2015-12-09	Cell
GB201514874D0 (en)	2015-10-07	Cell
TWI563718B (en)	2016-12-21	Vertical Transition Structure
GB201522097D0 (en)	2016-01-27	Cells
GB2561109B (en)	2020-06-24	Transition structure
GB201515000D0 (en)	2015-10-07	Reactor
SG11201709722TA (en)	2017-12-28	Reactor
GB201719541D0 (en)	2018-01-10	Cell Lines
PL3245344T3 (en)	2021-04-06	Post-beam construction
PL3370881T3 (en)	2022-05-16	Separator
HRP20190067T1 (en)	2019-02-22	Wall structure
SG11201709564VA (en)	2017-12-28	Reactor
GB201522223D0 (en)	2016-01-27	Therapeutic T cells
PL3257657T3 (en)	2021-12-13	Anti-spillage structure
GB201508845D0 (en)	2015-07-01	Risk stratification
SG11201803320YA (en)	2018-05-30	Separator
ZA201800972B (en)	2019-10-30	Methanogenesis
GB201514076D0 (en)	2015-09-23	Reactor
GB201514919D0 (en)	2015-10-07	Vessel
GB201506806D0 (en)	2015-06-03	Rheumatoid arthritis patient stratification
GB201509681D0 (en)	2015-07-22	Risk stratification
GB201508844D0 (en)	2015-07-01	Risk stratification

Legal Events

Date	Code	Title	Description
2016-10-19	AT	Applications terminated before publication under section 16(1)